Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 77 Nivolumab 64 Ipilimumab 40 Specimen Handling 33 Magnetic Resonance Spectroscopy 27 Cyclophosphamide 26 Biopsy 20 cemiplimab 16 fludarabine 14 Radiosurgery 14 relatlimab 13 CTLA-4 Antigen 13 binimetinib 12 Opdualag 12 trametinib 11 fludarabine phosphate 11 avelumab 9 Immunoglobulin G 9 Blood Specimen Collection 9 lifileucel 8 dabrafenib 8 atezolizumab 8 Radiotherapy 8 Disulfides 8 encorafenib 7 aldesleukin 7 X-Rays 7 Paclitaxel 7 Standard of Care 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

secukinumab × Dermatologic × 90 days × Clear all

NCT07237594 2026-06-04

REPLAY

Duke University

Phase 1 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡